Organon & Co (OGN)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 1,023,000 | 585,000 | 754,000 | 746,000 | 917,000 | 1,011,000 | 1,107,000 | 1,300,000 | 1,351,000 | |||
| Total stockholders’ equity | US$ in thousands | -70,000 | -589,000 | -555,000 | -737,000 | -892,000 | -1,066,000 | -1,137,000 | -1,250,000 | -1,508,000 | -1,618,000 | -1,934,000 | 4,722,000 |
| ROE | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,023,000K ÷ $-70,000K
= —
As the Return on Equity (ROE) values for Organon & Co. are not provided in the table, it is not possible to directly analyze the company's ROE performance based on the data presented. ROE is a key financial ratio that measures a company's profitability and efficiency in generating returns for its shareholders relative to their equity investment. In order to evaluate Organon & Co.'s ROE, it would be necessary to calculate this ratio using the formula:
ROE = Net Income / Shareholders' Equity
By comparing the calculated ROE values over the indicated quarters and across different periods, we can assess the company's ability to utilize its equity to generate profits. A higher ROE typically signifies better performance and efficiency in utilizing shareholder funds, while a declining or low ROE may indicate operational challenges or inefficient use of capital. Additionally, a comparative analysis of Organon & Co.'s ROE with industry benchmarks and competitors' ROE would provide further insights into the company's financial health and competitive position.
Peer comparison
Dec 31, 2023